Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency

A Multicentre, Open Label, Observational, Non-interventional Study to Evaluate the Long-term Safety and Efficacy of Norditropin® Formulation in Patients With AGHD

This study is conducted in Japan. The aim of this observational study is to collect information about the safety and efficacy of Norditropin® long-term treatment of growth hormone deficiency in adults.

Inclusion Criteria:

• Severe adult growth hormone deficiency

Exclusion Criteria:

• Known or suspected allergy to study product(s) or related products
• Previous participation in the study
• Diabetes Mellitus
• Presence of malignant tumor(s)
• Pregnant or likely to get pregnant